Aardvark Therapeutics, Inc. (AARD)

Aardvark Therapeutics Statistics

Total Valuation

AARD has a market cap or net worth of $274.56 million. The enterprise value is $148.76 million.

Market Cap	274.56M
Enterprise Value	148.76M

Important Dates

The next estimated earnings date is Tuesday, March 31, 2026, after market close.

Earnings Date	Mar 31, 2026
Ex-Dividend Date	n/a

Share Statistics

AARD has 21.77 million shares outstanding. The number of shares has increased by 282.40% in one year.

Current Share Class	21.77M
Shares Outstanding	21.77M
Shares Change (YoY)	+282.40%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	14.74%
Owned by Institutions (%)	20.39%
Float	11.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.24
P/TBV Ratio	2.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.03, with a Debt / Equity ratio of 0.00.

Current Ratio	12.03
Quick Ratio	11.77
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -48.06% and return on invested capital (ROIC) is -32.70%.

Return on Equity (ROE)	-48.06%
Return on Assets (ROA)	-30.81%
Return on Invested Capital (ROIC)	-32.70%
Return on Capital Employed (ROCE)	-43.65%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.48M
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	13.62
200-Day Moving Average	12.02
Relative Strength Index (RSI)	43.78
Average Volume (20 Days)	176,664

Short Selling Information

The latest short interest is 1.62 million, so 7.46% of the outstanding shares have been sold short.

Short Interest	1.62M
Short Previous Month	1.67M
Short % of Shares Out	7.46%
Short % of Float	14.62%
Short Ratio (days to cover)	7.38

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-53.47M
Pretax Income	-48.77M
Net Income	-48.77M
EBITDA	-53.44M
EBIT	-53.47M
Earnings Per Share (EPS)	-$3.21

Balance Sheet

The company has $126.35 million in cash and $545,000 in debt, with a net cash position of $125.81 million or $5.78 per share.

Cash & Cash Equivalents	126.35M
Total Debt	545,000
Net Cash	125.81M
Net Cash Per Share	$5.78
Equity (Book Value)	122.38M
Book Value Per Share	5.63
Working Capital	118.47M

Cash Flow

In the last 12 months, operating cash flow was -$45.09 million and capital expenditures -$101,000, giving a free cash flow of -$45.19 million.

Operating Cash Flow	-45.09M
Capital Expenditures	-101,000
Free Cash Flow	-45.19M
FCF Per Share	-$2.08

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AARD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-282.40%
Shareholder Yield	-282.40%
Earnings Yield	-17.76%
FCF Yield	-16.46%

Analyst Forecast

The average price target for AARD is $31.11, which is 144.58% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$31.11
Price Target Difference	144.58%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1